scispace - formally typeset
F

Flavia Bortolotti

Researcher at University of Padua

Publications -  129
Citations -  6065

Flavia Bortolotti is an academic researcher from University of Padua. The author has contributed to research in topics: Hepatitis & Hepatitis C. The author has an hindex of 37, co-authored 129 publications receiving 5859 citations. Previous affiliations of Flavia Bortolotti include University of Genoa & University of Pavia.

Papers
More filters
Journal ArticleDOI

Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

TL;DR: There is a growing understanding of viral, host and environmental factors influencing disease progression, which ultimately could improve the management of chronic hepatitis B.
Journal ArticleDOI

Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection

TL;DR: In HB s Ag-positive chronic active hepatitis presence of HB e Ag in serum identifies an early, although prolonged, phase of active virus replication that is frequently followed by the disappearance of complete virus particles from serum and appearance of anti-HB e .
Journal ArticleDOI

Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease

TL;DR: Over the course of a decade, few children with chronic HCV infection cleared viremia spontaneously, and those who did were more likely to have genotype 3, leading to end-stage liver disease in a small subgroup characterized by perinatal exposure, maternal drug use, and infection with HCV genotype 1a.
Journal ArticleDOI

Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.

TL;DR: The overall prognosis for chronic hepatitis B in horizontally infected Caucasian children is favorable; however, some patients progress to HCC and HBeAg‐negative hepatitis.
Journal ArticleDOI

Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children.

TL;DR: Pediatric HCV infection is usually mild, but few patients, especially those who are perinatally infected, clear viremia in the medium-term follow-up, and the higher rates of fibrosis observed in older patients suggest the possibility of an insidious progression of HCV-associated liver disease.